Subscribe

News
Watch
Conferences
Partners
CME/CE
Resources
Advisory Board
Subscribe

Spotlight -

This Year In Medicine 2025

Lindsay Fourman, MD

Lindsay Fourman, MD

Lindsay Fourman, MD, is an endocrinologist at Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School

Articles by Lindsay Fourman, MD

When to Add GLP-1 Receptor Agonists to Metreleptin in Lipodystrophy, With Lindsay Fourman, MD

When to Add GLP-1 Receptor Agonists to Metreleptin in Lipodystrophy, With Lindsay Fourman, MD

ByLindsay Fourman, MD

June 29th 2026

Real-world data highlight GLP-1 receptor agonist use with metreleptin in lipodystrophy and clinician guidance on timing and safety monitoring.

Real-World Data Suggest Synergy Between Metreleptin and GLP-1 Receptor Agonists in Lipodystrophy

Synergy Between Metreleptin and GLP-1 Receptor Agonists in Lipodystrophy Real-World Data Suggest

ByLindsay Fourman, MD

June 26th 2026

Lindsay Fourman, MD, discusses early real-world data exploring the use of GLP-1 receptor agonists alongside metreleptin in lipodystrophy.

Baseline METRE-PL Data Highlight Severe Metabolic Burden in Familial Partial Lipodystrophy

METRE-PL Data Shows Severe Metabolic Disease Burden in FPLD Despite Standard Therapy

ByLindsay Fourman, MD

June 24th 2026

First placebo-controlled phase 3 METRE-PL data show prevalent metabolic burden in familial partial lipodystrophy (FPLD) despite standard therapy.

Latest Updated Articles

Synergy Between Metreleptin and GLP-1 Receptor Agonists in Lipodystrophy Real-World Data Suggest
June 26th 2026

Trending on HCPLive

VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes

Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study

After Sickle Cell Gene Therapy, What Comes Next?

New Liver Cancer BEACON-HCC Framework Shows 96.6% Concordance in Pilot

DPP1 Inhibition in Bronchiectasis: Mechanism and Pivotal Trial Data